VERV Insider Trading

Insider Ownership Percentage: 26.40%
Insider Buying (Last 12 Months): $207,020.00
Insider Selling (Last 12 Months): $34,982,208.66

Verve Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Verve Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verve Therapeutics Share Price & Price History

Current Price: $21.65
Price Change: Price Decrease of -0.46 (-2.08%)
As of 12/9/2022 01:00 AM ET

This chart shows the closing price history over time for VERV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Verve Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2022Andrew BellingerCMOSell865$22.95$19,851.756,629View SEC Filing Icon  
11/29/2022Allison DorvalCFOSell554$22.10$12,243.402,186View SEC Filing Icon  
11/4/20222017 Gp L.L.C. GvMajor ShareholderSell97,166$31.14$3,025,749.24View SEC Filing Icon  
11/3/2022Krishna YeshwantDirectorSell49,568$32.79$1,625,334.724,308,630View SEC Filing Icon  
11/2/20222017 Gp L.L.C. GvMajor ShareholderSell57,303$35.94$2,059,469.82View SEC Filing Icon  
10/31/20222017 Gp L.L.C. GvMajor ShareholderSell107,393$38.64$4,149,665.52View SEC Filing Icon  
10/31/2022Krishna YeshwantDirectorSell53,696$38.64$2,074,813.444,418,813View SEC Filing Icon  
10/28/2022Andrew BellingerCMOSell10,000$39.90$399,000.006,629View SEC Filing Icon  
10/3/2022Sekar KathiresanCEOSell50,000$33.65$1,682,500.00317,839View SEC Filing Icon  
9/23/2022Andrew BellingerCMOSell60,000$35.34$2,120,400.006,629View SEC Filing Icon  
8/10/2022Sekar KathiresanCEOSell50,000$29.90$1,495,000.00317,839View SEC Filing Icon  
7/20/2022Andrew BellingerCMOSell20,000$34.90$698,000.006,629View SEC Filing Icon  
7/19/2022Sekar KathiresanCEOSell50,000$29.90$1,495,000.00317,839View SEC Filing Icon  
7/13/2022Andrew BellingerCMOSell10,000$24.90$249,000.006,629View SEC Filing Icon  
7/12/2022Fmr LlcInsiderSell163,000$20.78$3,387,140.00570,729View SEC Filing Icon  
7/1/2022Fmr LlcInsiderSell38,775$15.66$607,216.50773,729View SEC Filing Icon  
6/29/2022Fmr LlcInsiderSell34,409$15.59$536,436.31791,314View SEC Filing Icon  
5/12/2022Burt A. AdelmanDirectorBuy10,000$12.15$121,500.0018,700View SEC Filing Icon  
3/15/2022Burt A. AdelmanDirectorBuy4,000$21.38$85,520.00View SEC Filing Icon  
3/9/2022Fmr LlcInsiderSell3,971$29.01$115,198.71View SEC Filing Icon  
2/9/2022Fmr LlcInsiderSell13,190$29.46$388,577.40View SEC Filing Icon  
2/1/2022Fmr LlcInsiderSell35,574$29.04$1,033,068.96View SEC Filing Icon  
1/26/2022Fmr LlcInsiderSell149,853$31.23$4,679,909.19View SEC Filing Icon  
1/4/2022Sekar KathiresanCEOSell1,870$39.90$74,613.00View SEC Filing Icon  
12/28/2021Sekar KathiresanCEOSell6,693$39.90$267,050.70View SEC Filing Icon  
12/22/2021Andrew BellingerInsiderSell15,000$38.70$580,500.00View SEC Filing Icon  
12/22/2021Sekar KathiresanCEOSell57,000$38.71$2,206,470.00View SEC Filing Icon  
12/2/2021Andrew D. AsheInsiderBuy4,000$32.10$128,400.00View SEC Filing Icon  
12/2/2021Burt A. AdelmanDirectorBuy4,700$31.34$147,298.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Verve Therapeutics (NASDAQ:VERV)

59.51% of Verve Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VERV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Verve Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/8/2022Bank of New York Mellon Corp169,878$5.84M0.0%+64.0%0.276%Search for SEC Filing on Google Icon
11/21/2022California State Teachers Retirement System45,662$1.57M0.0%+42.2%0.074%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.10,974,011$376.96M19.2%N/A17.815%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.73,770$2.53M0.0%+83.5%0.120%Search for SEC Filing on Google Icon
11/15/2022State Street Corp2,799,834$96.17M0.0%+362.6%4.545%Search for SEC Filing on Google Icon
11/15/2022Temasek Holdings Private Ltd27,456$0.94M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP21,121$0.73M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.27,502$0.95M0.0%+83.3%0.045%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.3,658,812$125.68M0.0%+56.2%5.939%Search for SEC Filing on Google Icon
11/15/2022PFM Health Sciences LP1,168,808$40.15M1.5%+38.3%1.897%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD15,255$0.53M0.0%N/A0.025%Search for SEC Filing on Google Icon
11/15/2022Quantamental Technologies LLC7,254$0.25M0.1%N/A0.012%Search for SEC Filing on Google Icon
11/15/2022Martingale Asset Management L P16,273$0.56M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/15/2022Ensign Peak Advisors Inc6,280$0.22M0.0%+36.2%0.010%Search for SEC Filing on Google Icon
11/15/2022Federated Hermes Inc.1,749,737$60.10M0.2%+59.4%2.840%Search for SEC Filing on Google Icon
11/15/2022First Trust Advisors LP45,394$1.56M0.0%N/A0.074%Search for SEC Filing on Google Icon
11/15/2022BVF Inc. IL650,000$22.33M0.9%N/A1.055%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp169,878$5.84M0.0%+64.0%0.276%Search for SEC Filing on Google Icon
11/15/2022Bioimpact Capital LLC635,792$21.84M5.2%N/A1.032%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.3,376,210$115.97M0.0%+30.7%5.481%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada7,286$0.25M0.0%+544.2%0.012%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP600,000$20.61M1.4%-14.4%0.974%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC20,186$0.69M0.0%-84.0%0.033%Search for SEC Filing on Google Icon
11/14/2022Lazard Asset Management LLC1,879$64K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/14/2022Penserra Capital Management LLC13,719$0.47M0.0%+373.1%0.022%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC298,384$10.25M0.0%+99.7%0.484%Search for SEC Filing on Google Icon
11/14/2022MetLife Investment Management LLC24,677$0.85M0.0%+17.9%0.040%Search for SEC Filing on Google Icon
11/14/2022E Fund Management Co. Ltd.12,292$0.42M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/10/2022Credit Suisse AG28,644$0.98M0.0%+128.5%0.046%Search for SEC Filing on Google Icon
11/10/2022ARCH Venture Management LLC2,008,809$69M8.9%-19.9%3.261%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 6,139$0.21M0.0%+164.2%0.010%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG33,703$1.16M0.0%+22,368.7%0.056%Search for SEC Filing on Google Icon
11/9/2022Amalgamated Bank6,104$0.21M0.0%+25.7%0.010%Search for SEC Filing on Google Icon
11/9/2022SVB Wealth LLC6,025$0.21M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/9/2022Zurcher Kantonalbank Zurich Cantonalbank 4,612$0.16M0.0%+58.0%0.008%Search for SEC Filing on Google Icon
11/8/2022State Board of Administration of Florida Retirement System14,760$0.51M0.0%-23.6%0.025%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund30,642$1.05M0.0%+13.7%0.051%Search for SEC Filing on Google Icon
11/7/2022TD Asset Management Inc.13,542$0.46M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/7/2022Arizona State Retirement System8,746$0.30M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/7/2022ProShare Advisors LLC10,059$0.35M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/4/2022Vontobel Holding Ltd.10,000$0.34M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/3/2022Teacher Retirement System of Texas10,499$0.36M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC113,671$3.91M0.0%+2,240.8%0.189%Search for SEC Filing on Google Icon
11/2/2022DekaBank Deutsche Girozentrale23,000$0.80M0.0%N/A0.038%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC7,822$0.27M0.0%N/A0.013%Search for SEC Filing on Google Icon
10/28/2022NJ State Employees Deferred Compensation Plan14,000$0.48M0.1%N/A0.023%Search for SEC Filing on Google Icon
10/27/2022US Bancorp DE6,812$0.24M0.0%+1,278.9%0.011%Search for SEC Filing on Google Icon
10/27/2022Strs Ohio7,100$0.24M0.0%N/A0.012%Search for SEC Filing on Google Icon
10/24/2022High Net Worth Advisory Group LLC1,500$52K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/21/2022Sumitomo Mitsui Trust Holdings Inc.775,697$26.65M0.0%+573.2%1.290%Search for SEC Filing on Google Icon
10/18/2022Moody Aldrich Partners LLC34,036$1.17M0.2%N/A0.057%Search for SEC Filing on Google Icon
10/17/2022ARK Investment Management LLC3,393,859$116.58M0.8%+66.8%5.644%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.1,097,837$16.78M0.0%+54.6%1.831%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP114,117$1.74M0.0%N/A0.190%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.74,759$1.14M0.0%-29.7%0.125%Search for SEC Filing on Google Icon
8/15/2022Occudo Quantitative Strategies LP57,777$0.88M0.1%N/A0.096%Search for SEC Filing on Google Icon
8/15/2022State Street Corp605,283$9.25M0.0%-77.3%1.010%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC126,129$1.93M0.0%+415.5%0.210%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC371,671$5.68M0.0%N/A0.620%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.15,000$0.23M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/13/2022Quantbot Technologies LP6,500$99K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC311,200$4.76M0.0%N/A0.534%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.17,288$0.26M0.0%-4.5%0.030%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp280,915$4.29M0.0%+0.5%0.482%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG12,533$0.19M0.0%+3.4%0.021%Search for SEC Filing on Google Icon
8/12/2022FMR LLC5,315,779$81.23M0.0%+3.9%8.869%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers50,763$0.78M0.0%+37.3%0.087%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.1,354,638$20.70M0.0%+21.1%2.326%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank45,400$0.69M0.0%+13.8%0.078%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System19,320$0.30M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/4/2022Nikko Asset Management Americas Inc.115,232$1.49M0.0%+74.3%0.198%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.117,698$1.80M0.0%N/A0.242%Search for SEC Filing on Google Icon
7/26/2022Sumitomo Mitsui Trust Holdings Inc.115,232$1.76M0.0%N/A0.237%Search for SEC Filing on Google Icon
7/11/2022ARK Investment Management LLC2,034,124$30.84M0.2%+20.6%4.180%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank4,398$100K0.0%N/A0.009%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE211,394$4.82M0.0%+315.7%0.434%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC12,333$0.28M0.0%-74.4%0.025%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd5,253$0.12M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada2,571$58K0.0%-63.4%0.005%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP504,037$11.50M0.3%-44.2%1.036%Search for SEC Filing on Google Icon
5/17/2022Ensign Peak Advisors Inc4,610$0.11M0.0%+146.5%0.009%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System29,992$0.68M0.0%+32.0%0.062%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.106,368$2.43M0.0%+103.0%0.219%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP150,000$3.42M0.1%-14.8%0.308%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP2,346,047$53.54M0.0%-40.4%4.821%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP102,342$2.34M0.1%-79.5%0.210%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,663,106$60.77M0.0%+51.0%5.473%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.9,899$0.23M0.0%+35.7%0.020%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG106,251$2.42M0.0%+336.7%0.218%Search for SEC Filing on Google Icon
5/16/2022Novo Holdings A S750,000$17.12M0.7%+7.1%1.541%Search for SEC Filing on Google Icon
5/16/2022Ally Bridge Group NY LLC105,360$2.40M1.8%-4.5%0.217%Search for SEC Filing on Google Icon
5/13/2022Ameritas Investment Partners Inc.2,827$65K0.0%+133.4%0.006%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp279,499$6.38M0.0%+93.3%0.574%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.153,550$3.51M0.0%+46.6%0.316%Search for SEC Filing on Google Icon
5/13/2022Penserra Capital Management LLC2,040$46K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.710,237$16.21M0.0%+92.0%1.460%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.18,095$0.41M0.0%+115.5%0.037%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.2,318,775$52.92M0.0%+70.0%4.765%Search for SEC Filing on Google Icon
5/13/2022M28 Capital Management LP178,500$4.07M3.7%N/A0.367%Search for SEC Filing on Google Icon
5/12/2022Cibc World Market Inc.12,474$0.29M0.0%N/A0.026%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Verve Therapeutics logo
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Verve Therapeutics

Today's Range

Now: $21.65
Low: $21.23
High: $22.56

50 Day Range

MA: $28.62
Low: $19.71
High: $40.70

52 Week Range

Now: $21.65
Low: $10.70
High: $43.00

Volume

702,021 shs

Average Volume

894,621 shs

Market Capitalization

$1.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Who are the company insiders with the largest holdings of Verve Therapeutics?

Verve Therapeutics' top insider investors include:
  1. Krishna Yeshwant (Director)
  2. Fmr Llc (Insider)
  3. Sekar Kathiresan (CEO)
  4. Burt A Adelman (Director)
  5. Andrew Bellinger (CMO)
  6. Allison Dorval (CFO)
  7. 2017 Gp LLC Gv (Major Shareholder)
  8. Andrew Bellinger (Insider)
  9. Andrew D Ashe (Insider)
  10. Cormorant Asset Management, Lp (Insider)
  11. Logos Global Management Lp (Major Shareholder)
Learn More about top insider investors at Verve Therapeutics.

Who are the major institutional investors of Verve Therapeutics?

Verve Therapeutics' top institutional investors include:
  1. Alphabet Inc. — 17.81%
  2. Vanguard Group Inc. — 5.94%
  3. ARK Investment Management LLC — 5.64%
  4. BlackRock Inc. — 5.48%
  5. State Street Corp — 4.54%
  6. ARCH Venture Management LLC — 3.26%
Learn More about top institutional investors of Verve Therapeutics stock.

Which major investors are selling Verve Therapeutics stock?

Within the previous quarter, VERV stock was sold by these institutional investors:
  1. ARCH Venture Management LLC
  2. Cubist Systematic Strategies LLC
  3. Cormorant Asset Management LP
  4. State Board of Administration of Florida Retirement System
In the previous year, company insiders that have sold Verve Therapeutics company stock include:
  1. Krishna Yeshwant (Director)
  2. Fmr Llc (Insider)
  3. Sekar Kathiresan (CEO)
  4. Burt A Adelman (Director)
  5. Andrew Bellinger (CMO)
  6. Allison Dorval (CFO)
  7. 2017 Gp LLC Gv (Major Shareholder)
Learn More investors selling Verve Therapeutics stock.

Which major investors are buying Verve Therapeutics stock?

In the previous quarter, VERV stock was bought by institutional investors including:
  1. Alphabet Inc.
  2. State Street Corp
  3. ARK Investment Management LLC
  4. Vanguard Group Inc.
  5. BlackRock Inc.
  6. Sumitomo Mitsui Trust Holdings Inc.
  7. Federated Hermes Inc.
  8. BVF Inc. IL
During the last year, these company insiders have bought Verve Therapeutics stock:
  1. Krishna Yeshwant (Director)
  2. Fmr Llc (Insider)
  3. Sekar Kathiresan (CEO)
  4. Burt A Adelman (Director)
Learn More investors buying Verve Therapeutics stock.